Concepedia

Meike Dahlhaus

MD

9

Publications

734

Citations

9

H-Index

2010

Active since

Affiliations

Universität Ulm(Current)

University Hospital Ulm

University of Rostock

Meike Dahlhaus is an author at Universität Ulm specializing in cell biology, medicine, and immunology.

Top concepts

Publications per year

2010–2020

9

Publications

9

Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance

Camilla Jandus, Kayluz Frias Boligan, Obinna Chijioke et al. · Journal of Clinical Investigation · 2014 · 424 citations

The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.

Catrin Schult, Meike Dahlhaus, Äenne Glass et al. · PubMed · 2012 · 53 citations

Boolean modeling identifies Greatwall/MASTL as an important regulator in the AURKA network of neuroblastoma

Meike Dahlhaus, Andreas Burkovski, Falk Hertwig et al. · Cancer Letters · 2015 · 50 citations

, , +9

The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells

Catrin Schult, Meike Dahlhaus, Sabine Ruck et al. · BMC Cancer · 2010 · 49 citations · Full text

miR-146a regulates insulin sensitivity via NPR3

Julian Roos, Meike Dahlhaus, Jan‐Bernd Funcke et al. · Cellular and Molecular Life Sciences · 2020 · 43 citations · Full text

Rows per page

1–5 of 9